Suppr超能文献

聚合酶链反应(PCR)检测单克隆B细胞增殖的敏感性

Sensitivity of PCR in detecting monoclonal B cell proliferations.

作者信息

Ling F C, Clarke C E, Corbett W E, Lillicrap D P

机构信息

Department of Pathology, Queen's University, Kingston, Ontario, Canada.

出版信息

J Clin Pathol. 1993 Jul;46(7):624-7. doi: 10.1136/jcp.46.7.624.

Abstract

AIMS

To evaluate the rapid detection of various forms of monoclonal B cell proliferations by using the polymerase chain reaction (PCR) to identify clonal immunoglobulin heavy chain genomic rearrangements.

METHODS

Thirty four B cell lymphomas defined by morphology, immunophenotyping, and positive immunoglobulin heavy chain gene rearrangements detected by Southern blot analysis were examined. An additional 22 cases representing miscellaneous lymphoproliferative and non-lymphoproliferative disorders were also studied.

RESULTS

Monoclonal rearrangements were identified in 19 (56%) cases of B cell lymphoma. The method was less sensitive in the detection of follicular centre cell lymphomas (15 of 28, or 54%) than non-follicular centre cell lesions (four of six, or 67%). Monoclonal rearrangement was not identified in 19 control cases, including T cell lymphomas, Hodgkin's disease, reactive lymphadenopathy and metastatic carcinoma. Three cases showed positive immunoglobulin gene rearrangement by PCR but were negative on Southern blotting. Two of these cases had definite clinical, morphological, and immunophenotypic evidence of monoclonal B cell proliferation suggesting that PCR could, on occasion, pick up cases missed by Southern blotting and that the two methods are complementary in clonal lymphoproliferative disease diagnosis. The third case represented a "false positive" PCR reaction involving a colonic adenocarcinoma.

CONCLUSIONS

PCR analysis, using the primer sequences outlined in this study, will detect about 55% of clonal lymphoproliferative proliferations with increased sensitivity for non-follicular centre cell lesions. With these levels of detection in mind, this testing strategy can still be especially useful in cases which prove diagnostically problematic with standard morphological and immunophenotypic analysis, and in instances where the quantity and type of diagnostic material is limiting (needle aspirates and cellular fluids).

摘要

目的

通过聚合酶链反应(PCR)鉴定克隆性免疫球蛋白重链基因重排,评估其对各种形式单克隆B细胞增殖的快速检测能力。

方法

对34例经形态学、免疫表型分析及Southern印迹分析检测免疫球蛋白重链基因重排阳性的B细胞淋巴瘤进行检测。另外还研究了22例代表各种淋巴增殖性和非淋巴增殖性疾病的病例。

结果

19例(56%)B细胞淋巴瘤中鉴定出单克隆重排。该方法在检测滤泡中心细胞淋巴瘤时敏感性较低(28例中的15例,即54%),低于非滤泡中心细胞病变(6例中的4例,即67%)。19例对照病例中未鉴定出单克隆重排,包括T细胞淋巴瘤、霍奇金病、反应性淋巴结病和转移性癌。3例经PCR检测免疫球蛋白基因重排阳性,但Southern印迹检测为阴性。其中2例有明确的临床、形态学和免疫表型证据支持单克隆B细胞增殖,提示PCR有时可检测到Southern印迹遗漏的病例,两种方法在克隆性淋巴增殖性疾病诊断中具有互补性。第3例代表涉及结肠腺癌的“假阳性”PCR反应。

结论

使用本研究中概述的引物序列进行PCR分析,可检测约55%的克隆性淋巴增殖,对非滤泡中心细胞病变的敏感性更高。考虑到这些检测水平,这种检测策略在标准形态学和免疫表型分析诊断有问题的病例以及诊断材料的数量和类型有限(针吸活检和细胞液)的情况下仍特别有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d96/501390/7828db34cedd/jclinpath00208-0043-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验